Drugs
4
in active trials · 6 in all
Trials
6 active
10 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
TLR7/8 agonist |
Phase 2/3 | Dec 2026Phase 2 trial completes | |||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | NSCLC, Advanced Melanoma and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 1 Jun 2027Phase 1/2 trial completes | |||
| Next date | 1 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2028Phase 1/2 trial completes | |||
| Next date | Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | Mar 2029Phase 1/2 trial completes | |||
| Next date | Mar 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors and 5 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev